14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
THS vs EPC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Edgewell Personal Care Company (EPC) is the stronger overall head-to-head candidate over Treehouse Foods, Inc. (THS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). THS carries a Unified Composite Score of 43.6/100 (HOLD) at $24.43 (12.4x Forward P/E, 6.3% operating margin), whereas EPC carries 48.4/100 (HOLD) at $28.38 (14.3x Forward P/E, 7.3% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on THS vs EPC. Trailing 12-month operating profitability (THS 6.3% vs EPC 7.3%) and valuation multiples (THS 12.4x vs EPC 14.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Household & Personal Products value chain with $1.3B market capitalization and 7.3% operating margin.
OpEx & R&D Reinvestment35.7% of Rev ($713M)
90D Engineering Disclosures0 Published
Investor FAQ THS vs EPC Key Questions & Quantitative Answers
As of Nov 16, 2026, Edgewell Personal Care Company (EPC) is the stronger overall head-to-head candidate over Treehouse Foods, Inc. (THS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). THS carries a Unified Composite Score of 43.6/100 (HOLD) at $24.43 (12.4x Forward P/E, 6.3% operating margin), whereas EPC carries 48.4/100 (HOLD) at $28.38 (14.3x Forward P/E, 7.3% operating margin). Technically, THS sits in a Markup phase (RSI 58.8, UNCLASSIFIED options structure) and EPC sits in a Neutral phase (RSI 50.4, UNCLASSIFIED options structure).
EPC leads the Growth & Scale pillar: THS posts +0.1% YoY revenue growth and +734.1% YoY earnings growth on $3.34B TTM revenue (17.2% gross margin, 6.3% operating margin), compared with EPC at +3.0% YoY revenue growth and -53.4% YoY earnings growth on $2.00B TTM revenue (43.0% gross margin, 7.3% operating margin). On trailing 12-month operating scale, THS generates $3.34B in USD-normalized revenue versus $2.00B for EPC. In operating R&D and SG&A reinvestment, THS deploys 10.9% of Rev ($364M) (0 90-day corporate R&D disclosures) versus 35.7% of Rev ($713M) (0 disclosures) for EPC.
THS screens cheaper on headline valuation multiples. THS trades at 12.4x Forward P/E, 11.3x Trailing P/E, 0.30x PEG, and 0.4x EV/Revenue (10.4% EBITDA margin), whereas EPC trades at 14.3x Forward P/E, 13.5x Trailing P/E, 2.87x PEG, and 0.6x EV/Revenue (10.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against THS (-17.2% ROE) versus EPC (-0.1% ROE) capital efficiency.
In options market volatility and institutional positioning, THS carries 18.1% implied volatility (56th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.08β · 5% Vol realized risk). By comparison, EPC carries 40.9% implied volatility (5th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.32β · 52% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.